The safety and efficaly of Intensed Pulse Light in patients with meibomian gland dysfunction

The safety and efficaly of Intensed Pulse Light in patients with meibomian gland dysfunction - The safety and efficaly of IPLin MGD

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000022747

Enrollment

Registered

2016-06-16

Start date

2016-06-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Meibomian gland dysfunction

Interventions

IPL treatment 4 times for each 3 weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: meibomian gland dysfunction

Exclusion criteria

Exclusion criteria: Other ocular diseases, the history of ocular surgery within 3 months

Design outcomes

Primary

Measure	Time frame
meibum quality grading	—

Secondary

Measure	Time frame
Symptoms, Lipid layer thickness, BUT, meiboscore, Schirmer test, meniscus height, NIBUT	—

Countries

Japan

Contacts

Public ContactReiko Arita

Itoh Clinic Ophthalmology

ritoh@za2.so-net.ne.jp0486865588

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026